Entries by aaron

Pain control after TKA better with liposomal bupivacaine compared to conventional bupivacaine: study

Total knee arthroplasty (TKA) is a commonly performed procedure to alleviate pain and improve functional limitations caused by end-stage joint damage. Effective management of postoperative pain following TKA is crucial to the prevention of complications and enhancement of recovery. Adductor canal blocks (ACB) with conventional bupivacaine (CB) provide adequate analgesia after TKA, but carry a […]

Daytime Light Exposure Crucial for Better Sleep in Parkinson’s Disease, confirms study

Parkinson’s disease (PD) is associated with significant sleep disturbances, impacting patients’ overall well-being. Recent research suggests that light exposure plays a critical role in regulating sleep patterns. This study was published in the journal Sleep. PD patients often experience circadian rhythm disruptions and sleep difficulties, which can exacerbate their symptoms and decrease their quality of […]

Lebrikizumab demonstrates efficacy in atopic dermatitis and skin of color patients in first of its kind study

Atopic dermatitis (AD) is a chronic inflammatory skin disorder with limited treatment options for adolescents with moderate-to-severe disease. Lebrikizumab is a monoclonal antibody targeting interleukin (IL)-13. Researchers have found in first of its kind study that Lebrikizumab was associated with clinical benefit among patients atopic dermatitis and skin of color. In this study, treatment with […]

High cholesterol twice as prevalent among American Indian teens and young adults, reveals study

Young American Indians, ages 15-39, had cholesterol levels more than two times higher than the general U.S. population, according to new research published in the Journal of the American Heart Association , an open access, peer-reviewed journal of the American Heart Association. The researchers noted that previous research has estimated thatapproximately 25% of adolescents and approximately […]

Nirsevimab found Effective in Preventing RSV-Associated Hospitalizations Among Infants in new research

In a significant development in pediatric healthcare, nirsevimab, a long-acting monoclonal antibody, has demonstrated robust real-world effectiveness in protecting infants against respiratory syncytial virus (RSV)-associated hospitalizations, according to an analysis by the New Vaccine Surveillance Network during the period of October 1, 2023, to February 29, 2024. The report was published in CDC Morbidity and […]

MRI-Guided Focal Therapy Shows Promising 2-Year Outcomes for Intermediate-Risk Prostate Cancer: Study

Prostate cancer is a common malignancy affecting men worldwide, and intermediate-risk prostate cancer (PCa) presents a challenging treatment scenario. MRI-guided focal therapy (FT) has emerged as a promising approach, allowing for targeted treatment while preserving healthy prostate tissue. However, long-term outcomes of this technique remain underexplored. A recent study aimed to evaluate the 2-year oncological […]

How Effective isSingle Lung Ventilation with Double endotracheal tubes?

Recently published research paper discusses the effectiveness of single lung ventilation (SLV) using a double lumen tube (DLT) for providing surgical exposure in the thoracic cavity. It emphasizes the protective benefits of SLV for a healthy lung, highlighting the types of unhealthy lung fluids it protects from, such as blood, lavage fluid, malignant, or purulent […]

Once-weekly administration of apraglutide reduces dependency on parenteral support in short bowel syndrome: Phase 3 trial

USA: Findings from phase 3 STARS trial demonstrate the potential for apraglutide to improve the standard of care for all adult patients with short bowel syndrome with intestinal failure (SBS-IF) dependent on parenteral support as the only GLP-2 with once-weekly administration, if approved.  The study showed that treatment with apraglutide was associated with a reduction […]

FDA approves semaglutide for major heart disease prevention among obese

The US Food and Drug Administration (FDA) has approved semaglutide (Wegovy) for reducing risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight. Wegovy should be used in addition to a reduced calorie diet and increased physical activity. Cardiovascular disease is a group of diseases of the […]